Global Gene Editing Technology Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Table of Contents

1 Gene Editing Technology Market Overview

• 1.1 Product Overview and Scope of Gene Editing Technology
• 1.2 Classification of Gene Editing Technology by Type
  • 1.2.1 Global Gene Editing Technology Revenue by Type: 2015 VS 2019 VS 2025
  • 1.2.2 Global Gene Editing Technology Revenue Market Share by Type in 2019
  • 1.2.3 Homologous Recombination
  • 1.2.4 Meganuclease
• 1.3 Global Gene Editing Technology Market by Application
  • 1.3.1 Overview: Global Gene Editing Technology Revenue by Application: 2015 VS 2019 VS 2025
  • 1.3.2 Agriculture
  • 1.3.3 Medical
  • 1.3.4 Other
• 1.4 Global Gene Editing Technology Market by Regions
  • 1.4.1 Global Gene Editing Technology Market Size by Regions: 2015 VS 2019 VS 2025
  • 1.4.2 Global Market Size of Gene Editing Technology (2015-2025)
  • 1.4.3 North America (USA, Canada and Mexico) Gene Editing Technology Status and Prospect (2015-2025)
  • 1.4.4 Europe (Germany, France, UK, Russia and Italy) Gene Editing Technology Status and Prospect (2015-2025)
  • 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Gene Editing Technology Status and Prospect (2015-2025)
  • 1.4.6 South America (Brazil, Argentina, Colombia) Gene Editing Technology Status and Prospect (2015-2025)
  • 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Gene Editing Technology Status and Prospect (2015-2025)

2 Company Profiles

• 2.1 Thermo Fisher Scientific
  • 2.1.1 Thermo Fisher Scientific Details
  • 2.1.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.1.3 Thermo Fisher Scientific SWOT Analysis
  • 2.1.4 Thermo Fisher Scientific Product and Services
  • 2.1.5 Thermo Fisher Scientific Gene Editing Technology Revenue, Gross Margin and Market Share (2018-2019)
• 2.2 Allele Biotech
  • 2.2.1 Allele Biotech Details
  • 2.2.2 Allele Biotech Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.2.3 Allele Biotech SWOT Analysis
  • 2.2.4 Allele Biotech Product and Services
  • 2.2.5 Allele Biotech Gene Editing Technology Revenue, Gross Margin and Market Share (2018-2019)
• 2.3 Cellectics
  • 2.3.1 Cellectics Details
  • 2.3.2 Cellectics Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.3.3 Cellectics SWOT Analysis
  • 2.3.4 Cellectics Product and Services
  • 2.3.5 Cellectics Gene Editing Technology Revenue, Gross Margin and Market Share (2018-2019)
• 2.4 SIGMA ALDRICH
  • 2.4.1 SIGMA ALDRICH Details
  • 2.4.2 SIGMA ALDRICH Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.4.3 SIGMA ALDRICH SWOT Analysis
  • 2.4.4 SIGMA ALDRICH Product and Services
  • 2.4.5 SIGMA ALDRICH Gene Editing Technology Revenue, Gross Margin and Market Share (2018-2019)
• 2.5 Bio Rad
  • 2.5.1 Bio Rad Details
  • 2.5.2 Bio Rad Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.5.3 Bio Rad SWOT Analysis
  • 2.5.4 Bio Rad Product and Services
  • 2.5.5 Bio Rad Gene Editing Technology Revenue, Gross Margin and Market Share (2018-2019)
• 2.6 Dharmacon
  • 2.6.1 Dharmacon Details
  • 2.6.2 Dharmacon Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.6.3 Dharmacon SWOT Analysis
  • 2.6.4 Dharmacon Product and Services
  • 2.6.5 Dharmacon Gene Editing Technology Revenue, Gross Margin and Market Share (2018-2019)
• 2.7 Lonza
  • 2.7.1 Lonza Details
  • 2.7.2 Lonza Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.7.3 Lonza SWOT Analysis
  • 2.7.4 Lonza Product and Services
  • 2.7.5 Lonza Gene Editing Technology Revenue, Gross Margin and Market Share (2018-2019)
• 2.8 AstraZeneca
  • 2.8.1 AstraZeneca Details
  • 2.8.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.8.3 AstraZeneca SWOT Analysis
  • 2.8.4 AstraZeneca Product and Services
  • 2.8.5 AstraZeneca Gene Editing Technology Revenue, Gross Margin and Market Share (2018-2019)
• 2.9 CRISPR Therapeutics
  • 2.9.1 CRISPR Therapeutics Details
  • 2.9.2 CRISPR Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.9.3 CRISPR Therapeutics SWOT Analysis
  • 2.9.4 CRISPR Therapeutics Product and Services
  • 2.9.5 CRISPR Therapeutics Gene Editing Technology Revenue, Gross Margin and Market Share (2018-2019)
• 2.10 Recombinetics
  • 2.10.1 Recombinetics Details
  • 2.10.2 Recombinetics Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.10.3 Recombinetics SWOT Analysis
  • 2.10.4 Recombinetics Product and Services
  • 2.10.5 Recombinetics Gene Editing Technology Revenue, Gross Margin and Market Share (2018-2019)
• 2.11 GE Healthcare
  • 2.11.1 GE Healthcare Details
  • 2.11.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.11.3 GE Healthcare SWOT Analysis
  • 2.11.4 GE Healthcare Product and Services
  • 2.11.5 GE Healthcare Gene Editing Technology Revenue, Gross Margin and Market Share (2018-2019)
• 2.12 QIAGEN NV
  • 2.12.1 QIAGEN NV Details
  • 2.12.2 QIAGEN NV Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.12.3 QIAGEN NV SWOT Analysis
  • 2.12.4 QIAGEN NV Product and Services
  • 2.12.5 QIAGEN NV Gene Editing Technology Revenue, Gross Margin and Market Share (2018-2019)
• 2.13 Editas Medicine
  • 2.13.1 Editas Medicine Details
  • 2.13.2 Editas Medicine Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.13.3 Editas Medicine SWOT Analysis
  • 2.13.4 Editas Medicine Product and Services
  • 2.13.5 Editas Medicine Gene Editing Technology Revenue, Gross Margin and Market Share (2018-2019)
• 2.14 Agilent Technologies
  • 2.14.1 Agilent Technologies Details
  • 2.14.2 Agilent Technologies Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.14.3 Agilent Technologies SWOT Analysis
  • 2.14.4 Agilent Technologies Product and Services
  • 2.14.5 Agilent Technologies Gene Editing Technology Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

• 3.1 Global Gene Editing Technology Revenue and Share by Players (2015-2020)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Gene Editing Technology Players Market Share
  • 3.2.2 Top 10 Gene Editing Technology Players Market Share
• 3.3 Market Competition Trend

4 Market Size by Regions

• 4.1 Global Gene Editing Technology Revenue and Market Share by Regions
• 4.2 North America Gene Editing Technology Revenue and Growth Rate (2015-2020)
• 4.3 Europe Gene Editing Technology Revenue and Growth Rate (2015-2020)
• 4.4 Asia-Pacific Gene Editing Technology Revenue and Growth Rate (2015-2020)
• 4.5 South America Gene Editing Technology Revenue and Growth Rate (2015-2020)
• 4.6 Middle East & Africa Gene Editing Technology Revenue and Growth Rate (2015-2020)

5 North America Gene Editing Technology Revenue by Countries

• 5.1 North America Gene Editing Technology Revenue by Countries (2015-2020)
• 5.2 USA Gene Editing Technology Revenue and Growth Rate (2015-2020)
• 5.3 Canada Gene Editing Technology Revenue and Growth Rate (2015-2020)
• 5.4 Mexico Gene Editing Technology Revenue and Growth Rate (2015-2020)

6 Europe Gene Editing Technology Revenue by Countries

• 6.1 Europe Gene Editing Technology Revenue by Countries (2015-2020)
• 6.2 Germany Gene Editing Technology Revenue and Growth Rate (2015-2020)
• 6.3 UK Gene Editing Technology Revenue and Growth Rate (2015-2020)
• 6.4 France Gene Editing Technology Revenue and Growth Rate (2015-2020)
• 6.5 Russia Gene Editing Technology Revenue and Growth Rate (2015-2020)
• 6.6 Italy Gene Editing Technology Revenue and Growth Rate (2015-2020)

7 Asia-Pacific Gene Editing Technology Revenue by Countries

• 7.1 Asia-Pacific Gene Editing Technology Revenue by Countries (2015-2020)
• 7.2 China Gene Editing Technology Revenue and Growth Rate (2015-2020)
• 7.3 Japan Gene Editing Technology Revenue and Growth Rate (2015-2020)
• 7.4 Korea Gene Editing Technology Revenue and Growth Rate (2015-2020)
• 7.5 India Gene Editing Technology Revenue and Growth Rate (2015-2020)
• 7.6 Southeast Asia Gene Editing Technology Revenue and Growth Rate (2015-2020)

8 South America Gene Editing Technology Revenue by Countries

• 8.1 South America Gene Editing Technology Revenue by Countries (2015-2020)
• 8.2 Brazil Gene Editing Technology Revenue and Growth Rate (2015-2020)
• 8.3 Argentina Gene Editing Technology Revenue and Growth Rate (2015-2020)

9 Middle East & Africa Revenue Gene Editing Technology by Countries

• 9.1 Middle East & Africa Gene Editing Technology Revenue by Countries (2015-2020)
• 9.2 Saudi Arabia Gene Editing Technology Revenue and Growth Rate (2015-2020)
• 9.3 UAE Gene Editing Technology Revenue and Growth Rate (2015-2020)
• 9.4 Egypt Gene Editing Technology Revenue and Growth Rate (2015-2020)
• 9.5 South Africa Gene Editing Technology Revenue and Growth Rate (2015-2020)

10 Market Size Segment by Type

• 10.1 Global Gene Editing Technology Revenue and Market Share by Type (2015-2020)
• 10.2 Global Gene Editing Technology Market Forecast by Type (2019-2024)
• 10.3 Homologous Recombination Revenue Growth Rate (2015-2025)
• 10.4 Meganuclease Revenue Growth Rate (2015-2025)

11 Global Gene Editing Technology Market Segment by Application

• 11.1 Global Gene Editing Technology Revenue Market Share by Application (2015-2020)
• 11.2 Gene Editing Technology Market Forecast by Application (2019-2024)
• 11.3 Agriculture Revenue Growth (2015-2020)
• 11.4 Medical Revenue Growth (2015-2020)
• 11.5 Other Revenue Growth (2015-2020)

12 Global Gene Editing Technology Market Size Forecast (2021-2025)

• 12.1 Global Gene Editing Technology Market Size Forecast (2021-2025)
• 12.2 Global Gene Editing Technology Market Forecast by Regions (2021-2025)
• 12.3 North America Gene Editing Technology Revenue Market Forecast (2021-2025)
• 12.4 Europe Gene Editing Technology Revenue Market Forecast (2021-2025)
• 12.5 Asia-Pacific Gene Editing Technology Revenue Market Forecast (2021-2025)
• 12.6 South America Gene Editing Technology Revenue Market Forecast (2021-2025)
• 12.7 Middle East & Africa Gene Editing Technology Revenue Market Forecast (2021-2025)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Data Source
• 14.3 Disclaimer